Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
Bionano Genomics shares have lost about 17.7% since the beginning of the year versus the S&P 500's gain of 8.1%. Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to a loss of $1.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +6.17%. A quarter ago, it was expected that this company would post a loss of $0.81 per share when ...